November PBAC Agenda drops

Posted 31 July 2025 AM

The PBAC has dropped the agenda for its November meeting with 29 new listing requests and two new vaccines for the NIP - as 24 companies jostle for a recommendation.

Celltrion Healthcare has claimed first place with the highest number of new listing requests. The company is seeking recommendations for three biosimilars which could disrupt markets worth a combined $855 million on the PBS.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here